Andreas H. Diacon

3 ta ish

Stellenbosch University

1. Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline

   Andreas H. Diacon, Alexander S. Pym, Martin P. Grobusch +13

   MaqolaOAOchiq kirish20144 iqtibos

   ABIABI:AkademIndex/2026.other.034203

2. Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance

   Andreas H. Diacon, Peter R. Donald, Alexander S. Pym +11

   MaqolaOAOchiq kirish20123 iqtibos

   ABIABI:AkademIndex/2026.other.185768

3. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis

   Rodney Dawson, Andreas H. Diacon, Daniel E. Everitt +16

   Maqola20152 iqtibos

   ABIABI:AkademIndex/2026.other.364686